Research Associate post in the Institute of Cancer Therapeutics, part of the Institute of Health and Social Care at the University of Bradford. The work tests new hypoxia-selective cancer drugs in 2D and 3D cell models, probes how they act, and supports drug development through LC-MS analysis. The post is supported by a Wellcome Accelerator Award, and applications are encouraged from Black, Pakistani and Bangladeshi researchers. An enhanced DBS check applies, and a postgraduate degree or equivalent research experience is needed.
What the job involves
- Evaluate novel hypoxia-selective therapeutics in 2D and 3D cancer models, alone and with chemotherapy and radiotherapy
- Investigate mechanisms of action and therapeutic response using molecular and cellular biology, flow cytometry and gene editing
- Support translational drug development through LC-MS studies of activation, stability and pharmacokinetics
- Analyse data and disseminate findings
Qualifications
- MSc or PhD, or equivalent research experience, in cancer biology, pharmacology, molecular biology, biomedical sciences, pharmaceutical sciences or a related discipline
Experience
- Practical laboratory-based research in cancer biology, pharmacology, molecular biology, biomedical sciences or a related discipline
- Mammalian cell culture and in vitro biological assays
- Designing, conducting and analysing laboratory experiments and interpreting scientific data
Checks & eligibility
- Enhanced DBS check
What’s offered
- 25 days holiday plus 13 statutory and customary days
- Family-friendly policies
- Campus facilities
- Employer contribution pension scheme
- Salary sacrifice schemes
- Campus nursery
#J-18808-Ljbffr
Contact Details:
The Methodist Church in Britain Recruitment Team
